chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: felt tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (felt tired) in a 54-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 028A21A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included PREDNISONE, ALLOPURINOL, ROSUVASTATIN CALCIUM (CRESTOR) and ADALIMUMAB (HUMIRA) for an unknown indication.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (felt tired). On 31-Mar-2021, FATIGUE (felt tired) had resolved. Not Provided          Treatment medications were not provided by reporter.   This case was linked to MOD-2021-090361 (Patient Link).
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Palpitations, Pruritus
Clinical narrative: itch all over the body; palpitations; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (itch all over the body) and PALPITATIONS (palpitations) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028a21a and 043b21a) for COVID-19 vaccination.     Concurrent medical conditions included Psoriatic arthritis since 1987, Drug allergy (cefdinir) and Hashimoto's disease since 2010. Concomitant products included CETIRIZINE HYDROCHLORIDE (CETRIZINE) for Allergy, LEVOTHYROXINE SODIUM (SYNTHROID), LEVOTHYROXINE, CIPROFLOXACIN HYDROCHLORIDE;DEXAMETHASONE from 01-Apr-2021 to an unknown date and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (itch all over the body) and PALPITATIONS (palpitations). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (itch all over the body) and PALPITATIONS (palpitations) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 109 (Inconclusive) unknown.         Patient also took steroid shots  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable. ? Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-091092.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Initial Addiitonal-1 : VAERS On 28-May-2021: NNI FOLLOW UP -Translated document : VAERS translated WHERE no new information regarding dose 1possible NNI as all information given for dose 2
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Mild pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Mild pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Mild pain). At the time of the report, PAIN (Mild pain) had resolved.            This case was linked to MOD-2021-018251 (Patient Link).
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Palpitations, Pruritus, Rash
Clinical narrative: Palpitations; Generalized Itching/start to each different part of my body find it self too burning in itch; A rash all over her body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Generalized Itching/start to each different part of my body find it self too burning in itch), RASH (A rash all over her body) and PALPITATIONS (Palpitations) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043b21a and 028a21a) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Cefdinir allergy), Mosquito bite (Itchy), Hashimoto's disease since 2010 and Psoriatic arthritis since 1987. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and LIOTHYRONINE for Thyroid disorder NOS, MULTIVITAMIN [VITAMINS NOS] and CIPROFLOXACIN;DEXAMETHASONE from 01-Apr-2021 to 01-May-2021 for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced PRURITUS (Generalized Itching/start to each different part of my body find it self too burning in itch). 23-Apr-2021, the patient experienced RASH (A rash all over her body). On an unknown date, the patient experienced PALPITATIONS (Palpitations). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 1 dosage form and CETIRIZINE HYDROCHLORIDE (CETRIZINE) (oral) ongoing from 2016 for Adverse event, at a dose of 1 dosage form. On 27-Apr-2021, PRURITUS (Generalized Itching/start to each different part of my body find it self too burning in itch) had resolved. At the time of the report, RASH (A rash all over her body) outcome was unknown and PALPITATIONS (Palpitations) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 109 (High) 109.         The patient took cetirizine for the itching without relief ,and had to go to the emergency room  after a few days. She was prescribed steroids, Benadryl and other medicine. She was initially told to withhold the steroids because of an upcoming surgery, but because she experienced  palpitations after taking Benadryl, she went back to the emergency and was given the steroids, and felt relief after two hours.   This case was linked to MOD-2021-091047.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Significant Follow-up received on 28-MAY-2021 and contains updated information on patient history, allergies and events. On 28-May-2021: Initial Additional-1 : Merged from duplicate case MOD-2021-187596 On 28-May-2021: Translated document : Merged from Duplicate case MOD-2021-187596
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Myalgia, Pyrexia, Somnolence
Clinical narrative: No appetite; Slept and slept; Achy; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No appetite), SOMNOLENCE (Slept and slept), MYALGIA (Achy) and PYREXIA (Fever) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal and Thyroid disorder NOS. Concomitant products included ATENOLOL and LOSARTAN for Blood pressure, LEVOTHYROXINE for Thyroid disorder.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced DECREASED APPETITE (No appetite), SOMNOLENCE (Slept and slept), MYALGIA (Achy) and PYREXIA (Fever). On 22-Apr-2021, DECREASED APPETITE (No appetite), SOMNOLENCE (Slept and slept), MYALGIA (Achy) and PYREXIA (Fever) had resolved.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Cough, Headache
Clinical narrative: Felt a little bit foggy; Cough; Headache; This spontaneous case was reported by an other and describes the occurrence of CONFUSIONAL STATE (Felt a little bit foggy), COUGH (Cough) and HEADACHE (Headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), LOSARTAN POTASSIUM (LOSARTAN POTASSSIUM), HYDROCHLOROTHIAZIDE, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and PHLEBODIUM AUREUM EXTRACT (HELIOCARE) for an unknown indication.    On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced CONFUSIONAL STATE (Felt a little bit foggy), COUGH (Cough) and HEADACHE (Headache). At the time of the report, CONFUSIONAL STATE (Felt a little bit foggy), COUGH (Cough) and HEADACHE (Headache) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: little fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Apr-2021 and was forwarded to the company on 26-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (little fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (little fever). At the time of the report, PYREXIA (little fever) outcome was unknown.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: arm swelling; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swelling) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (arm swelling). At the time of the report, PERIPHERAL SWELLING (arm swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Per report, the patient received 2 doses of Moderna COVID-19 vaccine and experienced arm swelling after received doses. Treatment information was not reported.   This case was linked to MOD-2021-091442.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Illness, Pyrexia
Clinical narrative: Extremely Sick; Had a fever of 104 for 4 weeks; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Extremely Sick) and PYREXIA (Had a fever of 104 for 4 weeks) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Extremely Sick) and PYREXIA (Had a fever of 104 for 4 weeks). At the time of the report, ILLNESS (Extremely Sick) had resolved and PYREXIA (Had a fever of 104 for 4 weeks) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104 High.         The reporter stated her son-in-lawhad the Moderna vaccines and was fine with the first one, but with the second shot, he came down with a 104 fever for 4 weeks. He was extremely sick with the Moderna vaccine. He is fine now as far as they know. Caller declined safety report. Caller declined email. Concomitant medications and treatment was not reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Fatigue, Pain, Pruritus, Urticaria
Clinical narrative: hives; very itchy; very very tired, could not get out of bed; body was aching so badly; had temperature; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (body was aching so badly), BODY TEMPERATURE INCREASED (had temperature), URTICARIA (hives), PRURITUS (very itchy) and FATIGUE (very very tired, could not get out of bed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024MZOA and 011JZOA) for COVID-19 vaccination.     No medical history was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced PAIN (body was aching so badly), BODY TEMPERATURE INCREASED (had temperature) and FATIGUE (very very tired, could not get out of bed). On 07-Mar-2021, the patient experienced URTICARIA (hives) and PRURITUS (very itchy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 07-Mar-2021, PAIN (body was aching so badly), BODY TEMPERATURE INCREASED (had temperature) and FATIGUE (very very tired, could not get out of bed) had resolved. On 15-Mar-2021, URTICARIA (hives) and PRURITUS (very itchy) had resolved.            Concomitant medications were not provided.  Treatment medications also included:allergic pills, antibodies, and prednisone.   This case was linked to MOD-2021-034649 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza, Skin burning sensation
Clinical narrative: burning sensation of the skin; flu symptoms; Chills; This spontaneous case was reported by a consumer and describes the occurrence of SKIN BURNING SENSATION (burning sensation of the skin), INFLUENZA (flu symptoms) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced SKIN BURNING SENSATION (burning sensation of the skin), INFLUENZA (flu symptoms) and CHILLS (Chills). At the time of the report, SKIN BURNING SENSATION (burning sensation of the skin), INFLUENZA (flu symptoms) and CHILLS (Chills) outcome was unknown.            Concomitant product use was unknown by the reporter. Treatment information was not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-028409 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-028409:1ST Dose case
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dehydration, Dizziness, Pyrexia
Clinical narrative: Dehydrated; Dizziness; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DEHYDRATION (Dehydrated), DIZZINESS (Dizziness), PYREXIA (Fever) and CHILLS (Chills) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DEHYDRATION (Dehydrated), DIZZINESS (Dizziness), PYREXIA (Fever) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, DEHYDRATION (Dehydrated), DIZZINESS (Dizziness), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            Concomitant medications were unknown.     This case was linked to MOD-2021-030237 (Patient Link).   Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea
Clinical narrative: Diarrhea; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and NAUSEA (Nausea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced DIARRHOEA (Diarrhea) and NAUSEA (Nausea). At the time of the report, DIARRHOEA (Diarrhea) and NAUSEA (Nausea) outcome was unknown.            No treatment information was provided.  No concomitant medication was provided.   This case was linked to MOD-2021-018805 (Patient Link).
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: arm swelling; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swelling) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (arm swelling). At the time of the report, PERIPHERAL SWELLING (arm swelling) outcome was unknown.            Concomitant medications were not provided. Per report, the patient received 2 doses of Moderna COVID-19 vaccine and experienced arm swelling after received doses. Treatment information was not reported.   This case was linked to MOD-2021-091367 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of   in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.            No concomitant medications were provided by the reporter. Treatment information was not provided by the reporter.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: sore arm; flu-like symptoms; fever up to 101.8 degrees; Fatigue; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever up to 101.8 degrees), FATIGUE (Fatigue) and MYALGIA (Muscle aches) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and DILTIAZEM (CARDIZEM [DILTIAZEM]) for an unknown indication.    On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever up to 101.8 degrees), FATIGUE (Fatigue) and MYALGIA (Muscle aches). At the time of the report, PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever up to 101.8 degrees), FATIGUE (Fatigue) and MYALGIA (Muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information provided    This case was linked to MOD-2021-018308 (Patient Link).   Reporter did not allow further contact
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: not gotten menstrual period; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION DELAYED (not gotten menstrual period) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUATION DELAYED (not gotten menstrual period). At the time of the report, MENSTRUATION DELAYED (not gotten menstrual period) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant products were reported. No Treatment information reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Follow-up received on 27-APR-2021
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Painful right foot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Painful right foot) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Painful right foot). At the time of the report, PAIN IN EXTREMITY (Painful right foot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was unknown by the reporter. Treatment information was not provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Tooth injury
Clinical narrative: Has a cracked tooth and getting it pulled today; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH INJURY (Has a cracked tooth and getting it pulled today) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TOOTH INJURY (Has a cracked tooth and getting it pulled today). At the time of the report, TOOTH INJURY (Has a cracked tooth and getting it pulled today) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: lip swelling; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LIP SWELLING (lip swelling) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00B21A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included METHOTREXATE, ADALIMUMAB (HUMIRA), LEVOTHYROXINE, BUPROPION, PREDNISONE and FOLIC ACID for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced LIP SWELLING (lip swelling). On 25-Apr-2021, LIP SWELLING (lip swelling) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.  Scheduled to receive the second dose on 06May2021.  Patient stopped Methotrexate and Humira two weeks prior to receiving vaccine, resumed 2 weeks after
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Hypersensitivity, Rash, Rash erythematous, Rash pruritic
Clinical narrative: I had a severe allergic reaction; rash over her body; It's red, it burns, itches, & it's welting up; red, it burns, itches, & it's welting up; red, it burns, itches, & it's welting up; red, it burns, itches, & it's welting up; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (I had a severe allergic reaction), RASH (rash over her body), RASH ERYTHEMATOUS (It's red, it burns, itches, & it's welting up), BURNING SENSATION (red, it burns, itches, & it's welting up) and RASH PRURITIC (red, it burns, itches, & it's welting up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced RASH (rash over her body), RASH ERYTHEMATOUS (It's red, it burns, itches, & it's welting up), BURNING SENSATION (red, it burns, itches, & it's welting up), RASH PRURITIC (red, it burns, itches, & it's welting up) and URTICARIA (red, it burns, itches, & it's welting up). On an unknown date, the patient experienced HYPERSENSITIVITY (I had a severe allergic reaction). At the time of the report, HYPERSENSITIVITY (I had a severe allergic reaction), RASH (rash over her body), RASH ERYTHEMATOUS (It's red, it burns, itches, & it's welting up), BURNING SENSATION (red, it burns, itches, & it's welting up), RASH PRURITIC (red, it burns, itches, & it's welting up) and URTICARIA (red, it burns, itches, & it's welting up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication were reported. Treatment medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: I had a severe allergic reaction; rash over her body; It's red, it burns, itches, & it's welting up; red, it burns, itches, & it's welting up; red, it burns, itches, & it's welting up; red, it burns, itches, & it's welting up; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (I had a severe allergic reaction), RASH (rash over her body), RASH ERYTHEMATOUS (It's red, it burns, itches, & it's welting up), BURNING SENSATION (red, it burns, itches, & it's welting up) and RASH PRURITIC (red, it burns, itches, & it's welting up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced RASH (rash over her body), RASH ERYTHEMATOUS (It's red, it burns, itches, & it's welting up), BURNING SENSATION (red, it burns, itches, & it's welting up), RASH PRURITIC (red, it burns, itches, & it's welting up) and URTICARIA (red, it burns, itches, & it's welting up). On an unknown date, the patient experienced HYPERSENSITIVITY (I had a severe allergic reaction). At the time of the report, HYPERSENSITIVITY (I had a severe allergic reaction), RASH (rash over her body), RASH ERYTHEMATOUS (It's red, it burns, itches, & it's welting up), BURNING SENSATION (red, it burns, itches, & it's welting up), RASH PRURITIC (red, it burns, itches, & it's welting up) and URTICARIA (red, it burns, itches, & it's welting up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication were reported. Treatment medication was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dizziness, Hypertension, Pain in extremity
Clinical narrative: Dizzy spell; Episodes of high blood pressure; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), DIZZINESS (Dizzy spell) and HYPERTENSION (Episodes of high blood pressure) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     The patient's past medical history included GERD. Concurrent medical conditions included Blood pressure high.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 20-Apr-2021, the patient experienced DIZZINESS (Dizzy spell) and HYPERTENSION (Episodes of high blood pressure). On 13-Apr-2021, PAIN IN EXTREMITY (Sore arm) had resolved. On 20-Apr-2021, DIZZINESS (Dizzy spell) had resolved. At the time of the report, HYPERTENSION (Episodes of high blood pressure) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Apr-2021, Blood pressure measurement: 134/82 (High) Elevated. On 27-Apr-2021, Blood pressure measurement: 144/80 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  No treatment information was provided.  The patient stated that she quit smoking in 2020. Her average BP between 28-Mar-2021 and 10-Apr-2021 was 108/62. Her highest systolic reading was 155/80 and her highest diastolic reading was 142/91.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling hot, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Swollen arm that grows bigger each day; Red rash; Upper forearm is hot to touch; Upper forearm is sore; low-grade fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm that grows bigger each day), RASH ERYTHEMATOUS (Red rash), FEELING HOT (Upper forearm is hot to touch), PAIN IN EXTREMITY (Upper forearm is sore) and PYREXIA (low-grade fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0UUB21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Shellfish allergy. Concomitant products included PANTOPRAZOLE for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced PYREXIA (low-grade fever) and CHILLS (chills). On 25-Apr-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm that grows bigger each day), RASH ERYTHEMATOUS (Red rash), FEELING HOT (Upper forearm is hot to touch) and PAIN IN EXTREMITY (Upper forearm is sore). On 25-Apr-2021, PYREXIA (low-grade fever) and CHILLS (chills) outcome was unknown. At the time of the report, PERIPHERAL SWELLING (Swollen arm that grows bigger each day), RASH ERYTHEMATOUS (Red rash), FEELING HOT (Upper forearm is hot to touch) and PAIN IN EXTREMITY (Upper forearm is sore) outcome was unknown.            Concomitant products included Over-the-counter vitamin for an unknown indication. No treatment information was provided
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Swollen arm that grows bigger each day; Red rash; Upper forearm is hot to touch; Upper forearm is sore; low-grade fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm that grows bigger each day), RASH ERYTHEMATOUS (Red rash), FEELING HOT (Upper forearm is hot to touch), PAIN IN EXTREMITY (Upper forearm is sore) and PYREXIA (low-grade fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0UUB21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Shellfish allergy. Concomitant products included PANTOPRAZOLE for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced PYREXIA (low-grade fever) and CHILLS (chills). On 25-Apr-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm that grows bigger each day), RASH ERYTHEMATOUS (Red rash), FEELING HOT (Upper forearm is hot to touch) and PAIN IN EXTREMITY (Upper forearm is sore). On 25-Apr-2021, PYREXIA (low-grade fever) and CHILLS (chills) outcome was unknown. At the time of the report, PERIPHERAL SWELLING (Swollen arm that grows bigger each day), RASH ERYTHEMATOUS (Red rash), FEELING HOT (Upper forearm is hot to touch) and PAIN IN EXTREMITY (Upper forearm is sore) outcome was unknown.            Concomitant products included Over-the-counter vitamin for an unknown indication. No treatment information was provided
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dizziness, Pain in extremity
Clinical narrative: episodes of high blood pressure; dizzy spell; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (episodes of high blood pressure), DIZZINESS (dizzy spell) and PAIN IN EXTREMITY (Sore arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     Concurrent medical conditions included GERD and Blood pressure high.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 20-Apr-2021, the patient experienced BLOOD PRESSURE INCREASED (episodes of high blood pressure) and DIZZINESS (dizzy spell). On 13-Apr-2021, PAIN IN EXTREMITY (Sore arm) had resolved. On 20-Apr-2021, DIZZINESS (dizzy spell) had resolved. At the time of the report, BLOOD PRESSURE INCREASED (episodes of high blood pressure) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Blood pressure measurement: 108/62 108/62, 134/82 134/82., 144/80 144/80, 155/80 155/80 and 142/91 142/91.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  Treatment medication were not provided   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Follow-up(TCR) information received on 18-JUN-2021 contains non-significant information.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Rash
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of headache, fatigue (tiredness) and full body rash in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 008C21A) for COVID-19 immunization. The patient's past medical history included no adverse event. On Apr 24, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 24, 2021, patient experienced headache, fatigue (tiredness) and full body rash. At the time of the report, headache, fatigue (tiredness) and full body rash outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Treatment: steroid. No concomitant medication reported.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Pain in extremity
Clinical narrative: tiredness and pain in both his knees and legs; tiredness and pain in both his knees and legs; tiredness and pain in both his knees and legs; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (tiredness and pain in both his knees and legs), PAIN IN EXTREMITY (tiredness and pain in both his knees and legs) and FATIGUE (tiredness and pain in both his knees and legs) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011a21a and 016m20a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL and VITAMINS NOS for an unknown indication.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced ARTHRALGIA (tiredness and pain in both his knees and legs), PAIN IN EXTREMITY (tiredness and pain in both his knees and legs) and FATIGUE (tiredness and pain in both his knees and legs). At the time of the report, ARTHRALGIA (tiredness and pain in both his knees and legs), PAIN IN EXTREMITY (tiredness and pain in both his knees and legs) and FATIGUE (tiredness and pain in both his knees and legs) had not resolved.            Treatment information was not provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Rash pruritic
Clinical narrative: Blotches on the forearm; Rashes on her body, they were itchy; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Blotches on the forearm) and RASH PRURITIC (Rashes on her body, they were itchy) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (Blotches on the forearm) and RASH PRURITIC (Rashes on her body, they were itchy). At the time of the report, RASH MACULAR (Blotches on the forearm) and RASH PRURITIC (Rashes on her body, they were itchy) outcome was unknown.            No concomitant medications were provided. No treatment drugs were reported. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Little Sore Arm/Arm just sore after 2nd vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Little Sore Arm/Arm just sore after 2nd vaccine) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 120L20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced MYALGIA (Little Sore Arm/Arm just sore after 2nd vaccine). On 15-Feb-2021, MYALGIA (Little Sore Arm/Arm just sore after 2nd vaccine) had resolved. Not provided          Concomitant product use was not provided by the reporter.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-092047, -MODERNATX, INC.-MOD-2021-028972 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Non-significant follow up Received on 28-MAY-2021 contains ; Sender's Comments:  -MODERNATX, INC.-MOD-2021-092047:Daughters case -MODERNATX, INC.-MOD-2021-028972:Son in law's case-phone number is matching in this case with mothers case
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Vaccination site erythema, Vaccination site induration, Vaccination site pruritus
Clinical narrative: red hot; hard; itchy; red; Sore arm; Tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE WARMTH (red hot), VACCINATION SITE INDURATION (hard), VACCINATION SITE PRURITUS (itchy) and FATIGUE (Tired) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032120A and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hiatal hernia (Started years ago), GERD, High cholesterol and Hay fever. Concurrent medical conditions included Penicillin allergy (Hives Started years ago), Drug allergy (Hives Started years ago) and Hypersensitivity NOS. Concomitant products included SIMVASTATIN for Cholesterol, OMEPRAZOLE for Hiatal hernia, store brand SPECTRAVITE PERFORMANCE, ASPIRIN [ACETYLSALICYLIC ACID], CALCIUM, VITAMIN D [VITAMIN D NOS], VITAMIN C [ASCORBIC ACID] and FISH OIL for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tired). In February 2021, the patient experienced VACCINATION SITE WARMTH (red hot), VACCINATION SITE INDURATION (hard), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red). In February 2021, PAIN IN EXTREMITY (Sore arm), VACCINATION SITE WARMTH (red hot), VACCINATION SITE INDURATION (hard), VACCINATION SITE PRURITUS (itchy), FATIGUE (Tired) and VACCINATION SITE ERYTHEMA (red) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment information is provided.  Patient does not have history of Anaphylaxis, Hives/ Urticaria, or Asthma.  Doctor has done many blood tests mainly for autoimmune diseases all came back negative on an unspecified date.   This case was linked to MOD-2021-133344 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow-up doc received on 27-Apr-2021in which Conmeds, Medical History and Information pertaining to dose 1 events updated On 01-Jun-2021: follow-up doc received on 01-jun-2021
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: red hot; hard; itchy; red; Sore arm; Tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE WARMTH (red hot), VACCINATION SITE INDURATION (hard), VACCINATION SITE PRURITUS (itchy) and FATIGUE (Tired) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032120A and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hiatal hernia (Started years ago), GERD, High cholesterol and Hay fever. Concurrent medical conditions included Penicillin allergy (Hives Started years ago), Drug allergy (Hives Started years ago) and Hypersensitivity NOS. Concomitant products included SIMVASTATIN for Cholesterol, OMEPRAZOLE for Hiatal hernia, store brand SPECTRAVITE PERFORMANCE, ASPIRIN [ACETYLSALICYLIC ACID], CALCIUM, VITAMIN D [VITAMIN D NOS], VITAMIN C [ASCORBIC ACID] and FISH OIL for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tired). In February 2021, the patient experienced VACCINATION SITE WARMTH (red hot), VACCINATION SITE INDURATION (hard), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red). In February 2021, PAIN IN EXTREMITY (Sore arm), VACCINATION SITE WARMTH (red hot), VACCINATION SITE INDURATION (hard), VACCINATION SITE PRURITUS (itchy), FATIGUE (Tired) and VACCINATION SITE ERYTHEMA (red) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment information is provided.  Patient does not have history of Anaphylaxis, Hives/ Urticaria, or Asthma.  Doctor has done many blood tests mainly for autoimmune diseases all came back negative on an unspecified date.   This case was linked to MOD-2021-133344 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow-up doc received on 27-Apr-2021in which Conmeds, Medical History and Information pertaining to dose 1 events updated On 01-Jun-2021: follow-up doc received on 01-jun-2021